S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
DIS   132.86 (+1.53%)
S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
DIS   132.86 (+1.53%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 REDHILL BIOPHAR/SBioXcel TherapeuticsAVEO PharmaceuticalsAmerican Brivision (Holding)XOMA
SymbolNASDAQ:RDHLNASDAQ:BTAINASDAQ:AVEOOTCMKTS:ABVCNASDAQ:XOMA
Price Information
Current Price$6.17$5.80$0.92$6.63$18.41
52 Week RangeBuyBuyBuyN/ABuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/ABuy
Consensus Price Target$20.00$22.33$2.55N/A$27.50
% Upside from Price Target224.15% upside285.06% upside177.17% upsideN/A49.38% upside
Trade Information
Market Cap$133.62 million$100.52 million$147.85 million$129.15 million$159.85 million
Beta1.262.960.710.351.27
Average Volume69,04167,2024,270,2031,89259,322
Sales & Book Value
Annual Revenue$8.36 millionN/A$5.41 millionN/A$5.30 million
Price / Sales16.19N/A27.34N/A30.32
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.41 per share$2.49 per share($0.22) per shareN/A$2.24 per share
Price / Book2.56N/A-4.18N/A8.22
Profitability
Net Income$-38,820,000.00$-19,270,000.00$-5,330,000.00N/A$-13,340,000.00
EPS($1.70)($1.32)($0.19)N/A($1.59)
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-561.47%N/A-46.69%N/A-72.20%
Return on Equity (ROE)-93.55%-77.72%-50.69%N/A-51.91%
Return on Assets (ROA)-68.95%-66.59%45.09%N/A-12.77%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.10%0.04%6.84%N/A1.39%
Current Ratio2.84%3.93%2.21%0.12%3.90%
Quick Ratio2.71%3.93%2.21%0.12%3.90%
Ownership Information
Institutional Ownership Percentage37.69%19.05%29.55%N/A44.47%
Insider Ownership PercentageN/A64.80%3.80%49.60%9.89%
Miscellaneous
Employees751817911
Shares Outstanding21.94 million15.73 million160.74 million19.48 million8.73 million
Next Earnings Date11/12/2019 (Estimated)11/8/2019 (Estimated)11/8/2019 (Estimated)11/8/2019 (Estimated)11/6/2019 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableNot Optionable
 REDHILL BIOPHAR/SBioXcel TherapeuticsAVEO PharmaceuticalsAmerican Brivision (Holding)XOMA

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel